Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

Literature DB >> 9144897

Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

O Alfthan¹, K Jauhiainen, E Kaasinen, T Liukkonen.

Abstract

A survey on superficial, local urinary bladder cancer, its prognostic factors, and instillation treatments is presented on the basis of experience with approximately 1,000 patients over a period of 20 years, experimental investigations, and the literature. Personal opinions and practical recommendations are presented in 11 conclusive theses.

Entities: Disease Species

Mesh：

Year: 1997 PMID： 9144897 DOI： 10.1007/bf02201978

Source DB: PubMed Journal: World J Urol ISSN： 0724-4983 Impact factor: 4.226

Keyword Cloud
References

46 in total

1. Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study.

Authors: K Jauhiainen; M Sotarauta; J Permi; O Alfthan
Journal: Eur Urol Date: 1986 Impact factor: 20.096

2. Intravesical cytostatics: pH-dependence of antitumour activity.

Authors: K Jauhiainen; L Kangas; H Käpylä; O Alfthan
Journal: Urol Res Date: 1985

3. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group.

Authors: T J Liukkonen; P K Lipponen; M Helle; K E Jauhiainen
Journal: Urol Res Date: 1997

4. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.

Authors: K H Kurth; F H Schröder; U Tunn; R Ay; M Pavone-Macaluso; F Debruyne; M de Pauw; O Dalesio; F ten Kate
Journal: J Urol Date: 1984-08 Impact factor: 7.450

5. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

Authors: M P Raitanen; P Nieminen; T L Tammela
Journal: Br J Urol Date: 1995-10

Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

1. Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study.

2. Intravesical cytostatics: pH-dependence of antitumour activity.

3. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group.

4. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.

5. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

6. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.

7. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.

8. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences.

9. Review of Mayo Clinic experience with carcinoma in situ.

Review 10. Biologic response modifiers in genitourinary neoplasia.